P. D. Hinduja Adopts Ibhar to digitize their IPC and AMS program
P. D. Hinduja Adopts Ibhar to digitize their IPC and AMS program
P. D. Hinduja Hospital, a renowned healthcare institution in Mumbai, has partnered with Ibhar. This collaboration marks a significant step forward in enhancing patient care through digital transformation.
The initiative focuses on digitalizing P. D. Hinduja Hospital’s Infection Prevention & Control (IPC) and Antimicrobial Stewardship (AMSP) programs. This innovative endeavour harnesses the capabilities of Artificial Intelligence (AI) and Machine Learning (ML) to bolster healthcare standards, with a paramount emphasis on enhancing patient safety and elevating clinical outcomes and revolutionize its approach to managing infections and antibiotic usage.
Joy Chakraborty, COO – P. D. Hinduja Hospital and Medical Research Centre, affirmed, “P. D. Hinduja Hospital has been at the forefront of providing quality healthcare to its patients. The hospital has taken up steps in this direction earlier, both clinical and non-clinical, for the past many years. This step of adopting Ibhar is in the same direction to provide better quality care to patients.”
Dr. Camilla Rodrigues, Consultant Microbiologist and Chairperson of the Infection Control Committee, P. D. Hinduja Hospital and Medical Research Centre, affirmed, “P. D. Hinduja Hospital has always kept high standards with respect to infection prevention and control. The hospital’s infection control rates are benchmarked for better performance. The hospital has always been an early adopter of protocols, technologies and services in the direction of infection prevention and control. Partnering with Ibhar Technologies is yet another step in this direction.”
Mr C. Bernard, Managing Director of Ibhar, said, “We are glad to be associated with P. D. Hinduja Hospital in this endeavour of creating a transformative clinical governance ecosystem. Through a comprehensive suite of solutions, Ibhar aspires to establish a foundation built on robust value creation and the consistent application of standardised practices. The implementation of this cutting-edge technology promises a multitude of advantages, not only ensuring the continued competency of valued staff but also streamlining cumbersome paperwork. Furthermore, it will significantly bolster compliance with essential infection control practices, safeguarding the health and well-being of everyone involved.”
Supported and sponsored by the Association of Healthcare Providers India (AHPI) and Pfizer, this partnership underscores a commitment to advancing healthcare standards and addressing critical challenges like Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAIs).
Alarming Statistics on AMR and HAIs:
According to the World Health Organization (WHO), HAIs affect hundreds of millions of patients worldwide annually, with 5-10% of patients in developed countries acquiring at least one HAI during their hospital stay. This rate is significantly higher in developing nations.
HAIs contribute to an estimated 99,000 deaths annually in the United States alone, as reported by the Centers for Disease Control and Prevention (CDC). Globally, HAIs are responsible for approximately 700,000 deaths each year, making them a major public health concern.
The AMR crisis is escalating, with projections indicating that by 2050, AMR could cause up to 10 million deaths annually if left unchecked. A rapid rise in antibiotic-resistant infections across various healthcare settings has been observed, particularly in countries like India.
The implementation of Ibhar’s advanced digital solutions empowers healthcare professionals at P. D. Hinduja Hospital with real-time data insights, enabling early infection identification, precise antibiotic prescription, and continuous monitoring of antibiotic use. This data-driven approach enhances patient outcomes and contributes to global efforts in combating AMR.
By adopting Ibhar’s state-of-the-art solutions, the hospital reinforces its commitment to delivering exceptional patient care and staying at the forefront of healthcare advancements.
Sources
